Please ensure Javascript is enabled for purposes of website accessibility

3 Fantastic Growth Stocks That Could Easily Make You a Fortune

By Keith Speights - Mar 4, 2021 at 6:05AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The wind is definitely at the backs of these high-flying stocks.

Let's face it: Not every stock will be a winner. Some will deliver only so-so returns. Others will be absolute disasters. However, including the right stocks in your portfolio can more than make up for the not-so-right ones over the long run.

Which stocks are most likely to be kinds of winners that be game-changers for your financial future? Here are three fantastic growth stocks that could easily make you a fortune.

Smiling young woman holding a smartphone with images of dollar signs around it

Image source: Getty Images.

1. DermTech

What if there was a better way to determine if a person has skin cancer than having a dermatologist cut out a chunk of the individual's flesh? What if that way was even more accurate than the current method of analyzing tissue biopsies? And what if it was also cheaper than the current approach? One company has addressed all of these "what ifs" -- DermTech (DMTK -8.77%).

DermTech specializes in skin genomics. Its current product on the market, Pigmented Lesion Assay (PLA), uses an adhesive patch that is placed over a suspicious area on the skin. The patch is removed then sent to DermTech where a genomic analysis is performed. Results are available within 72 hours that determine if a person has melanoma.

This approach is 17 times less likely to miss a diagnosis of melanoma than the current tissue biopsy approach is. It's also roughly 24% less expensive. Unsurprisingly, DermTech continues to secure reimbursement from major payers, including Medicare and several Blue Cross Blue Shield plans.

The company is also developing skin genomics products targeting other types of skin cancer. DermTech estimates that its total addressable market is around $10 billion. With the company's market cap below $2 billion, I think DermTech is exactly the kind of stock where you'll want to have skin in the game.

2. Etsy

Remember the wildly popular Bernie Sanders mitten memes that circulated after Inauguration Day? Etsy (ETSY -10.47%) sold $1.9 million of similar mittens and Bernie-related products within the next few days. This underscores just how much the company's platform has become the go-to site for unique homemade items.

In 2020, e-commerce sales skyrocketed because of the COVID-19 pandemic. But Etsy grew nearly 2.5 times faster than the e-commerce industry as a whole. It's now the fourth-largest retail e-commerce site based on monthly visits.

Etsy CFO Rachel Glaser acknowledged in the company's Q4 conference call that growth rates in 2021 won't be as mindblowing as what Etsy delivered in 2020. As the economy reopens more fully, consumers will likely spend more of their discretionary income on other things such as travel and entertainment. However, the long-term prospects for Etsy look very good.

In the past, the company thought that its total addressable market stood at close to $250 billion. The pandemic, though, has shown Etsy that it can go after a much larger market that's in the ballpark of $1.7 trillion. No, Etsy won't come close to capturing all of this market. But it doesn't have to for the stock to be a massive winner over the next decade and beyond.

3. Skillz

The average mobile gamer spends 17 minutes per day playing online. But the average user on the Skillz (SKLZ -3.78%) mobile gaming platform spends a whopping 62 minutes online each day. That's more, by the way, than TikTok, Facebook, and YouTube users spend on those sites. 

There's a reason why Skillz is so popular. Its platform attracts game developers -- roughly 10 million of them. And it attracts mobile gamers through its focus on head-to-head competition, tournaments, and prizes.

Look for Skillz to pick up even more momentum in the near future. The company recently inked a deal with the National Football League to host a global game developer challenge in the second quarter of this year to create an NFL-themed mobile game. This game will run on the Skillz platform and will be promoted by the NFL and Skillz.

Skillz stock skyrocketed after the NFL deal was announced in early February. However, its market cap remains at only $11 billion despite the surge. Skillz targets a mobile gaming market of around $68 billion annually. The company appears to be in a great position to claim increasingly more of this market. Like DermTech and Etsy, Skillz should make a fortune for investors who buy now and hold on for the long term. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Skillz Inc. Stock Quote
Skillz Inc.
SKLZ
$1.78 (-3.78%) $0.07
Meta Platforms, Inc. Stock Quote
Meta Platforms, Inc.
FB
$192.24 (-5.12%) $-10.38
Etsy, Inc. Stock Quote
Etsy, Inc.
ETSY
$78.84 (-10.47%) $-9.22
DermTech, Inc. Stock Quote
DermTech, Inc.
DMTK
$6.66 (-8.77%) $0.64

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
349%
 
S&P 500 Returns
122%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.